What I gather from today's announcement is that new Customer announcement is still tricky in US and seems to be in next quarter, however today's announcement has proven 4DX technology's XV LVAS® is ready for commercialisation in such a colossal market. I believe there will be something cheerful information in coming quarterly report to make shareholders gain confidence.
Ann: 4DMedical progresses towards full reimbursement in the US, page-3
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
53.0¢ |
Change
-0.050(8.62%) |
Mkt cap ! $217.5M | |||
| Open | High | Low | Value | Volume |
| 57.5¢ | 57.5¢ | 52.5¢ | $945.4K | 1.730M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 151700 | 53.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 54.0¢ | 55780 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |